Unstable and thalassemic α chain hemoglobin variants: A cause of Hb H disease and thalassemia intermedia

Hemoglobin

Volumn 32, Issue 4, 2008, Pages 327-349

  Wajcman, Henri ^a,f   Traeger Synodinos, Jan ^b   Papassotiriou, Ioannis ^c   Giordano, Piero C ^d   Harteveld, Cornelis L ^d   Baudin Creuza, Véronique ^a   Old, John ^e  

^a INSERM   (France)

^b UNIVERSITY OF ATHENS   (Greece)

^c AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e CHURCHILL HOSPITAL   (United Kingdom)

^f HENRI MONDOR HOSPITAL   (France)

Author keywords

Hb stabilizing protein (AHSP); Thalassemias; Hemoglobin (Hb); Unstable Hbs

Indexed keywords

ALPHA GLOBIN; ALPHA HEMOGLOBIN STABILIZING PROTEIN; HEMOGLOBIN ADANA; HEMOGLOBIN AGHIA SOPHIA; HEMOGLOBIN AGRINIO; HEMOGLOBIN AMSTERDAM; HEMOGLOBIN BLEULAND; HEMOGLOBIN BRONOVO; HEMOGLOBIN BRONTE; HEMOGLOBIN CHARTRES; HEMOGLOBIN CLINIC; HEMOGLOBIN DARTMOUTH; HEMOGLOBIN EVANSTON; HEMOGLOBIN EVORA; HEMOGLOBIN FOGGIA; HEMOGLOBIN GROENE HART; HEMOGLOBIN H; HEMOGLOBIN HERAKLION; HEMOGLOBIN LLEIDA; HEMOGLOBIN OEGSTGEEST; HEMOGLOBIN PETAH TIKVA; HEMOGLOBIN QUESTEMBERT; HEMOGLOBIN QUONG SZE; HEMOGLOBIN SALLANCHES; HEMOGLOBIN SUAN DOK; HEMOGLOBIN SUN PRAIRIE; HEMOGLOBIN VARIANT; HEMOGLOBIN VOREPPE; HEMOGLOBIN ZURICH ALBISRIEDEN; UNINDEXED DRUG;

ALPHA THALASSEMIA; ANEMIA; CODON; ERYTHROCYTE; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE PHENOTYPE CORRELATION; HEMOLYSIS; HEMOLYTIC ANEMIA; HETEROZYGOTE; HUMAN; MISSENSE MUTATION; POINT MUTATION; REVIEW; THALASSEMIA INTERMEDIA;

ALPHA-THALASSEMIA; GLOBINS; HEMOGLOBINS, ABNORMAL; HUMANS; PRECIPITATION; PROTEIN BINDING; VARIATION (GENETICS);

EID: 47949117716     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.1080/03630260802173833     Document Type: Review

References (82)

1. Higgs DR. Molecular mechanisms of α thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, Eds. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. Cambridge: Cambridge University Press. 2001; 405-430.
2. Chan V, Chan VWY, Tang M, Lau K, Todd D, Chan TK. Molecular defects in Hb H hydrops fetalis. Br J Haematol 1997; 96(2):224-228.
3. Clegg JB, Weatherall DJ, Milner PF. Haemoglobin Constant Spring - a chain termination mutant? Nature 1971; 234(5328):337-340.
4. Clegg JB, Weatherall DJ, Contopoulos-Griva I, Caroutsos K, Poungouras P, Tsevrenis H. Haemoglobin Icaria, a new chain termination mutant which causes α-thalassaemia. Nature 1974; 251(5472):245-247.
5. de Jong WW, Meera Khan P, Bernini LF. Hemoglobin Koya Dora: high frequency of a chain termination mutant. Am J Hum Genet 1975; 27(1):81-90.
6. Bradley TB, Wohl RC, Smith GJ. Elongation of the α-globin chain in a black family: interaction with Hb G Philadelphia. Clin Res 1975; 23:131A.
7. Merritt D, Jones RT, Head C, Thibodeau SN, Fairbanks VF, Steinberg MH, Coleman MB, Rodgers GP. Hb Seal Rock [(α2)142 Term→Glu, codon 142 TAA→ GAA]: an extended α chain variant associated with anemia, microcytosis, and α-thalassemia-2 (-3.7 kb). Hemoglobin 1997; 21(4):331-344.
8. Waye JS, Eng B, Patterson M, Chui DHK, Olivieri NF. Identification of a novel termination codon mutation (TAA→TAT, Term→Tyr) in the α2 globin gene of a Laotian girl with Hemoglobin H disease. Blood 1994; 83(11):3418-3420.
9. Harteveld CL, Traeger-Synodinos J, Ragusa A, Fichera M, Kanavakis E, Kattamis C, Giordano P, Schilirò G, Bernini LF. Different geographic origins of Hb Constant Spring [α2 codon 142 TAA→CAA]. Haematologica 2001; 86(1):36-38.
10. Singsanan S, Fucharoen G, Savongsy O, Sanchaisuriya K, Fucharoen S. Molecular characterization and origins of Hb Constant Spring and Hb Paksé in Southeast Asian populations. Ann Hematol 2007; 86(9):665-669.
11. Schrier SL, Bunyaratvej A, Khuhapinant A, Fucharoen S, Aljurf M, Snyder LM, Keifer CR, Ma L, Mohandas N. The unusual pathobiology of Hemoglobin Constant Spring red blood cells. Blood 1997; 89(5):1762-1769.
12. Turbpaiboon C, Limjindaporn T, Wongwiwat W, U-Pratya Y, Siritanaratkul N, Yenchitsomanus PT, Jitrapakdee S, Wilairat P. Impaired interaction of α-haemoglobin-stabilising protein with α-globin termination mutant in a yeast two-hybrid system. Br J Haematol 2006; 132(3):370-373.
13. 0 thalassaemia with Hb Icaria: three unusual cases of haemoglobinopathy H. Br J Haematol 1996; 92(2):332-335.
14. Kanavakis E, Papassotiriou I, Karagiorga M, Vrettou C, Metaxotou-Mavrommati A, Stamoulakatou A, Kattamis C, Traeger-Synodinos J. Phenotypic and molecular diversity of Haemoglobin H disease: a Greek experience. Br J Haematol 2000; 111(2):915-923.
15. Efremov GD. Thalassemias and other hemoglobinopathies in the Republic of Macedonia. Hemoglobin 2007; 31(1):1-15.
16. Henderson SJ, Sykes H, McCarthy J, Molyneux AT, Gallienne A, Old JM. Mild haemolytic anaemia due to homozygosity for Hb Icaria, α2 stop codon TAA→AAA. Br J Haematol 2007; 137(Suppl 1):72-73.
17. Galacteros F, Girodon E, M'Rad A, Martin J, Goossens M, Jaber L, Cohen IJ, Tamary H, Goshen Y, Zaizov R, Wajcman H. Hb Taybe (α38 or 39 THR deleted): an α-globin defect, silent in the heterozygous state and producing severe hemolytic anemia in the homozygous. C R Acad Sci III 1994; 317(5):437-444.
18. Oron-Karni V, Filon D, Shifrin Y, Fried E, Pogrebijsky G, Oppenheim A, Rund D. Diversity of α-globin mutations and clinical presentation of α-thalassemia in Israel. Am J Hematol 2000; 65(3):196-203.
19. Pobedimskaya DD, Molchanova TP, Streichman S, Huisman THJ. Compound heterozygosity for two α-globin gene defects, Hb Taybe (α1; 38 or 39 minus Thr) and a poly A mutation (α2; AATAAA→AATAAG), results in a severe hemolytic anemia. Am J Hematol 1994; 47(3):198-202.
20. Arnon S, Tamary H, Dgany O, Litmanovitz I, Regev R, Bauer S, Dolfin T, Yacobovich J, Wolach B, Jaber L. Hydrops fetalis associated with homozygosity for Hemoglobin Taybe (α38/39 THR deletion) in newborn triplets. Am J Hematol 2004; 76(3):263-266.
21. +-thalassemia mutations. Hemoglobin 2008; 32(4):371-378.
22. Yu X, Kong Y, Dore LC, Abdulmalik O, Katein AM, Zhou S, Choi JK, Gell D, Mackay JP, Gow AJ, Weiss MJ. An erythroid chaperone that facilitates folding of α-globin subunits for hemoglobin synthesis. J Clin Invest 2007; 117(7):1856-1865.
23. Morlé F, Francina A, Ducrocq R, Wajcman H, Gonnet C, Philippe N, Souillet G, Godet J. A new α chain variant Hb Sallanches [α2 104(G11) Cys→Tyr] associated with Hb H disease in one homozygous patient. Br J Haematol 1995; 91(3):608-611.
24. Waye JS, Walker L, Chui DH, Lafferty J, Kirby M. Homozygous Hb Sallanches [α104(G11)Cys→ Tyr] in a Pakistani child with Hb H disease. Hemoglobin 2000; 24(4):355-357.
25. Khan SN, Butt FI, Riazuddin S, Galanello R. Hb Sallanches [α104(G11)Cys→Tyr]: a rare α2-globin chain variant found in the homozygous state in three members of a Pakistani family. Hemoglobin 2000; 24(1):31-35.
26. Dash S, Harano K, Menon S. Hb Sallanches [α104(G11)Cys→Tyr, TGC→TAC (α2)]: an unstable hemoglobin variant found in an Indian child. Hemoglobin 2006; 30(3):393-396.
27. Hall GW, Thein SL, Newland AC, Chisholm M, Traeger-Synodinos J, Kanavakis E, Kattamis C, Higgs DR. A base substitution (T→C) in codon 29 of the α2 globin gene causes α thalassaemia. Br J Haematol 1993; 85(3):546-552.
28. 0-thalassemia associated with early onset of thalassemia major syndrome. Haematologica 2005; 90(1):ECR04.
29. Traeger-Synodinos J, Metaxotou-Mavromati A, Kanavakis E, Vrettou C, Papassotiriou I, Michael T, Kattamis C. An α-thalassemic hemoglobinopathy: homozygosity for the Hb Agrinio α2-globin chain variant. Hemoglobin 1998; 22(3):209-215.
30. Traeger-Synodinos J, Papassotiriou I, Metaxotou-Mavrommati A, Vrettou C, Stamoulakatou A, Kanavakis E. Distinct phenotypic expression associated with a new hyperunstable α globin variant (Hb Heraklion, α1cd37(C2) Pro→0): comparison to other α-thalassemic hemoglobinopathies. Blood Cells Mol Dis 2000; 26(4):276-284.
31. Ho PJ, Rochette J, Rees DC, Fisher CA, Huehns ER, Will AM, Thein SL. Hb Sun Prairie: diagnostic pitfalls in thalassemic hemoglobinopathies. Hemoglobin 1996; 20(2):103-112.
32. Lacerra G, Musollino G, Di Noce F, Prezioso R, Carestia C. Genotyping for known Mediterranean α-thalassemia point mutations using a multiplex amplification refractory mutation system. Haematologica 2007; 92(2):254-255.
33. Honig GR, Shamsuddin M, Vida LN, Mompoint M, Valcourt E, Bowie LJ, Jones EC, Powers PA, Spritz RA, Guis M, Embury SH, Conboy J, Kan YW, Mentzer WC, Weil SC, Hirata RK, Waloch J, O'Riordan JF, Goldstick TK. Hemoglobin Evanston (α14 Trp→Arg). An unstable α-chain variant expressed as α-thalassemia. J Clin Invest 1984; 73(6):1740-1749.
34. Moo-Penn WF, Baine RM, Jue DL, Johnson MH, McGuffey JE, Benson JM. Hemoglobin Evanston: α14(A12) Trp→Arg. A variant hemoglobin associated with α-thalassemia-2. Biochim Biophys Acta 1983; 747(1-2):65-70.
35. Harteveld CL, Wijermans PW, de Ree JELM, Ter Hal P, Van Delft P, Van Rooijen-Nijdam IH, Rasp E, Kok PJMJ, Souverijn JHM, Versteegh FGA, Giordano PC. A new Hb Evanston allele [α14(A12)Trp→Arg] found solely, and in the presence of common α-thalassemia deletions, in three independent Asian cases. Hemoglobin 2004; 28(1):1-5.
36. Das R, Garewal G, Shaji RV, Ahluwalia J, Bali HK, Varma S. Investigation of persistent hypochromic microcytosis unmasks Hemoglobin Evanston [α14(A12)Try→Arg] in a patient of cyclic thrombocytopenia preceding Takayasu's disease. Hematology 2005; 10(5):427-429.
37. Regtuijt ME, Harteveld CL, Van Delft P, Akkermans N, Giordano PC. Hb Suan-Dok [α109(G16)Leu→Arg; CTG→CGG (α2)] described in a patient of African ancestry. Hemoglobin 2004; 28(3):173-176.
38. Weiss I, Cash FE, Coleman MB, Pressley A, Adams JG, Sanguansermsri T, Liebhaber SA, Steinberg MH. Molecular basis for α-thalassemia associated with the structural mutant Hemoglobin Suan-Dok (α2 109Leu→Arg). Blood 1990; 76(12):2630-2636.
39. 3.7 gene. Hemoglobin 2008; 32(4):419-424.
40. Waye JS, Chui DHK. Hb Evora [α2-35, Ser→Pro], a novel hemoglobin variant associated with an α-thalassemia phenotype. Haematologica 2007; 92(5):E68.
41. Gomes S, Picanço I, Miranda A, Seixas MT, Oliveira M, Romão L, Faustino P. Hb Evora [á2-35(B16), Ser→Pro], a novel hemoglobin variant associated with an α-thalassemia phenotype. Haematologica 2007; 92(2):252-253.
42. Douna V, Papassotiriou I, Metaxotou-Mavrommati A, Stamoulakatou A, Liapi D, Kampourakis D, Tsilimigaki A, Kanavakis E, Traeger-Synodinos J. Further identification of the hyperunstable α globin chain variant Hb Heraklion [codons 36/37 (-CCC); Pro→0 (α1)] in Greek cases with co-inherited α+-thalassemia mutations. Hemoglobin 2008; 32(4):379-385.
43. 2, a severely unstable α1-globin variant, observed in combination with the -(α)20.5 kb α-thal-1 deletion in two Turkish patients. Am J Hematol 1993; 44(4):270-275.
44. 0 thalassaemia deletion and Hb Adana, α2 codon 59 GGC→GAC. Br J Haematol 2007; 137(Suppl 1):72.
45. +-thalassemia deletion: clinical aspects in two cases. Hemoglobin 2008; 32(4):361-369.
46. McBride KL, Snow K, Kubik KS, Fairbanks VF, Hoyer JD, Fairweather RB, Chaffee S, Edwards WH. Hb Dartmouth [α66(E15)Leu→Pro (α2) (CTG→CCG)]: a novel α2-globin gene mutation associated with severe neonatal anemia when inherited in trans with Southeast Asian α-thalassemia-1. Hemoglobin 2001; 25(4):375-382.
47. Honig GR, Shamsuddin M, Zaizov R, Steinherz M, Solar I, Kirschmann C. Hemoglobin Petah Tikva (α110 Ala→Asp): a new unstable variant with α-thalassemia-like expression. Blood 1981; 57(4):705-711.
48. Goossens M, Lee KY, Liebhaber SA, Kan YW. Globin structural mutant α125Leu→Pro is a novel cause of α-thalassaemia. Nature 1982; 296(5860):864-865.
49. Pan HF, Long GF, Li Q, Feng YN, Lei ZY, Wei HW, Huang YY, Huang JH, Lin N, Xu QQ, Ling SY, Chen XJ, Huang T. Current status of thalassemia in minority populations in Guangxi, China. Clin Genet 2007; 71(5):419-426.
50. Quong Szeα mutation in a Chinese woman. Eur J Haematol 2005; 75(3):259-261.
51. Traeger-Synodinos J, Harteveld CL, Kanavakis E, Giordano PC, Kattamis C, Bernini LF. Hb Aghia Sophia [α62(E11)Val→0 (α1)], an "in-frame" deletion causing α-thalassemia. Hemoglobin 1999; 23(4):317-324.
52. Harteveld CL, van Delft P, Plug R, Versteegh FGA, Hagen B, van Rooijen I, Kok PJMJ, Wajcman H, Kister J, Giordano PC. Hb Groene Hart: a new Pro→Ser amino acid substitution at position 119 of the α1-globin chain is associated with a mild α-thalassemia phenotype. Hemoglobin 2002; 26(3):255-260.
53. 3.7 deletion. Hemoglobin 2005; 29(4):263-268.
54. Giordano PC, Zweegman S, Akkermans N, Arkesteijn SGJ, van Delft P, Versteegh FGA, Wajcman H, Harteveld CL. The first case of Hb Groene Hart [α119(H2)Pro→Ser, CCT→TCT (α1)] homozygosity confirms that a thalassemia phenotype is associated with this abnormal hemoglobin variant. Hemoglobin 2007; 31(2):179-182.
55. Vasseur-Godbillon C, Marden MC, Giordano P, Wajcman H, Baudin-Creuza V. Impaired binding of AHSP to α chain variants: Hb Groene Hart illustrates a mechanism leading to unstable hemoglobins with α thalassemic like syndrome. Blood Cells Mol Dis 2006; 37(3):173-179.
56. Wajcman H, Vasseur C, Blouquit Y, Rosa J, Labie D, Najman A, Reman O, Leporrier M, Galacteros F. Unstable α-chain hemoglobin variants with factitious β-thalassemia biosynthetic ratio: Hb Questembert (α131[H14]Ser→Pro) and Hb Caen (α132[H15]Val→Gly). Am J Hematol 1993; 42(4):367-374.
57. Stamoulakatou A, Athanasiou-Metaxa M, Traeger-Synodinos J, Lazaropoulou C, Harteveld K, Premetis E, Tsantali H, Zorai A, Giordano P, Papassotiriou I, Kanavakis E. Rare thalassemic syndrome caused by interaction of Hb Questembert (α1 codon 131, TCT→CCT, Ser→Pro) with an α-thalassemia-2 deletion: implications for diagnosis and management. Blood Cells Mol Dis 2004; 32(1):118-123.
58. Rochette J, Barnetson R, Thein SL, Varet B, Valensi F. Hb Questembert is due to a base substitution (T→C) in codon 131 of the α2-globin gene and has an α-thalassemia biosynthetic ratio. Am J Hematol 1995; 48(4):289-290.
59. Harteveld CL, Vervloet M, Zweegman S, van Delft P, Akkermans N, Arkestijn S, Giordano PC. Hb Amsterdam [α32(B13)Met→Ile (α2)]: a new unstable variant associated with an α-thalassemia phenotype and a new African polymorphism. Hemoglobin 2005; 29(4):257-262.
60. 2-globin gene variant: Hb Chartres [α33(B14) Phe→Ser]. Hemoglobin 2003; 27(2):111-115.
61. +-thalassemia: Hb Zurich Albisrieden [α59(E8)Gly→Arg (α2)]. Hemoglobin 2004; 28(4):347-351.
62. Nakatsuji T, Miwa S, Ohba Y, Miyaji T, Matsumoto N, Matsuoka I. Hemoglobin Tottori (á59[E8] glycine→valine) a new unstable hemoglobin. Hemoglobin 1981; 5(5):427-439.
63. Ayala S, Colomer D, Gelpí JL, Corrons JL. α-Thalassaemia due to a single codon deletion in the α1-globin gene. Computational structural analysis of the new α-chain variant. Mutations in brief no. 132. Online. Hum Mutat 1998; 11(5):412.
64. Wajcman H, Dahmane M, Préhu C, Costes B, Promé D, Arous N, Bardakdjian-Michau J, Riou J, Ayache KC, Godart C, Galactéros F. Haemoglobin J-Biskra: a new mildly unstable α1 gene variant with a deletion of eight residues (α50-57, α51-58 or α52-59) including the distal histidine. Br J Haematol 1998; 100(2):401-406.
65. +-thalassemia phenotype. Hemoglobin 2003; 27(3):149-159.
66. Harteveld CL, Steen G, Vlasveld LT, van Delft P, Giordano PC. Hb Bronovo, a new globin gene mutation at α2 103 (His→Leu) associated with an α thalassemia phenotype. Haematologica 2006; 91(4):570-571.
67. Harteveld CL, Rozendaal L, Blom NA, Lo-A-Njoe S, Akkerman N, Arkestijn S, Van Delft P, Giordano PC. Hb Oegstgeest [α104(G11)Cys→Ser (α1)]. A new hemoglobin variant associated with a mild α-thalassemia phenotype. Hemoglobin 2005; 29(3):165-169.
68. Harteveld CL, Versteegh FGA, Kok PJMJ, van Rooijen-Nijdam IH, van Delft P, Giordano PC. Hb Bleuland [α108(G15)Thr→Asn, ACC→ AAC (α2)]: a new abnormal hemoglobin associated with a mild α-thalassemia phenotype. Hemoglobin 2006; 30(3):349-354.
69. Ayala S, Colomer D, Pujades A, Aymerich M, Vives Corrons JL. Haemoglobin Lleida: a new α2-globin variant (12 bp deletion) with mild thalassaemic phenotype. Br J Haematol 1996; 94(4):639-644.
70. Lacerra G, Scarano C, Musollino G, Flagiello A, Pucci P, Carestia C. Hb Foggia or α117(GH5)Phe→Ser: a new α2 globin allele affecting the αHb-AHSP interaction. Haematologica 2008; 93(1):141-142.
71. Feng L, Zhou S, Gu L, Gell DA, Mackay JP, Weiss MJ, Gow AJ, Shi Y. Structure of oxidized α-haemoglobin bound to AHSP reveals a protective mechanism for haem. Nature 2005; 435(7042):697-701.
72. Joly P, Pégourié B, Courby S, Barro C, Besson G, Cohen L, Garcia C, Francina A. Two new α-thalassemia point mutations not detectable by biochemical techniques. Hemoglobin 2008; 32(4):411-417.
73. +-thalassemia: Hb Plasencia [α125(H8) Leu→Arg (α2)]. Hemoglobin 2005; 29(2):113-117.
74. Harteveld CL, Giordano PC, Losekoot M, Heister JG, Batelaan D, van Delft P, Bruin MC, Bernini LF. Hb Utrecht [α2 129(H12)Leu→Pro], a new unstable α2-chain variant associated with a mild α-thalassaemic phenotype. Br J Haematol 1996; 94(3):483-485.
75. Darbellay R, Mach-Pascual S, Rose K, Graf J, Beris P. Haemoglobin Tunis-Bizerte: a new α1 globin 129 Leu→Pro unstable variant with thalassaemic phenotype. Br J Haematol 1995; 90(1):71-76.
76. 68. Blood Cells Mol Dis 2003; 31(2):234-239.
77. Waye JS, Eng B, Patterson M, Carcao MD, Chang L, Olivieri NF, Chui DHK. Identification of two new α-thalassemia mutations in exon 2 of the α1-globin gene. Hemoglobin 2001; 25(4):391-396.
78. +-thalassemia: a second observation. Hemoglobin 2004; 28(2):137-143.
79. Rahbar S, Lee C, Fairbanks VF, McCormick DJ, Kubik K, Madden BJ, Nozari G. Hb Watts [α74(EF3) or α75(EF4)Asp→0]: a shortened α chain variant due to the deletion of three nucleotides in exon 2 of the α2-globin gene. Hemoglobin 1997; 21(4):321-330.
80. Ohba Y, Miyaji T, Matsuoka M, Yokoyama M, Numakura H. Hemoglobin Hirosaki (α43[CE1]Phe→Leu), a new unstable variant. Biochim Biophys Acta 1975; 405(1):155-160.
81. Beretta A, Prato V, Gallo E, Lehmann H. Haemoglobin Torino α43 (CD1) phenylalanine→valine. Nature 1968; 217(5133):1016-1018.
82. 0 thalassemia associated with transfusion-dependent Hb H disease. Am J Hematol 2004; 75(3):157-63.